PRECLINICAL STUDY
Left Ventricular Eccentric Remodeling and Matrix Loss Are Mediated by Bradykinin and Precede Cardiomyocyte Elongation in Rats With Volume Overload
Thomas D. Ryan, MD, PhD*,3,
Emily C. Rothstein, PhD*,2,3,
Inmaculada Aban, PhD ,
Jose A. Tallaj, MD , ,
Ahsan Husain, PhD*, ,
Pamela A. Lucchesi, PhD*,1 and
Louis J. DellItalia, MD*, , ,*
* Departments of Physiology and Biophysics, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama
Department of Biostatistics, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama
Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama
Birmingham Veteran Affairs Medical Center, Birmingham, Alabama.
Manuscript received March 28, 2006;
revised manuscript received May 25, 2006,
accepted June 19, 2006.
* Reprint requests and correspondence: Dr. Louis J. DellItalia, Center for Heart Failure Research, University of Alabama at Birmingham, 432 BMR2, 901 19th Street South, Birmingham, Alabama 35294-2180. (Email: loudell{at}uab.edu).
OBJECTIVES: We hypothesized that left ventricular (LV) remodeling and matrix loss in volume overload (VO) are mediated by bradykinin (BK) and exacerbated by chronic angiotensin-converting enzyme (ACE) inhibition.
BACKGROUND: Chronic ACE inhibition increases anti-fibrotic BK and does not attenuate LV remodeling in pure VO. The relative contribution of changes in extracellular matrix versus cardiomyocyte elongation in acute and chronic LV chamber remodeling during VO is unknown.
METHODS: Echocardiography, LV collagen content, and isolated cardiomyocytes were studied in rats after aortocaval fistula (ACF) of 12 h, 2 and 5 days, and 4, 8, and 15 weeks. We also studied ACF rats after BK2 receptor (BK2R) blockade (2 days) or ACE inhibition (4 weeks).
RESULTS: At 2 days after ACF, LV end-diastolic dimension (LVEDD)/wall thickness was increased, and LV interstitial collagen was decreased by 50% without cardiomyocyte elongation. The BK2R blockade prevented collagen loss and normalized LVEDD/wall thickness. From 4 to 15 weeks after ACF, interstitial collagen decreased by 30% and left ventricular end-systolic (LVES) dimension increased despite normal LVES pressure and isolated cardiomyocyte function. The ACE inhibition did not decrease LVEDD/wall thickness, further decreased LV interstitial collagen, and did not improve LV fractional shortening despite decreased LVES pressure.
CONCLUSIONS: Immediately after ACF induction, eccentric LV remodeling is mediated by interstitial collagen loss without cardiomyocyte elongation. Acute BK2R blockade prevents eccentric LV remodeling and improves function. Chronic ACE inhibition does not prevent eccentric LV remodeling or improve function. These findings suggest that ACE inhibitor-mediated increase in LV BK exacerbates matrix loss and explains why ACE inhibition is ineffective in VO.
|
Abbreviations and Acronyms
| | ACE = angiotensin-converting enzyme | | ACF = aortocaval fistula | | BK = bradykinin | | BK2R = BK receptor type 2 | | LV = left ventricle/ventricular | | LVED = left ventricular end-diastolic | | LVEDD = left ventricular end-diastolic dimension | | LVES = left ventricular end-systolic | | LVESD = left ventricular end-systolic dimension | | MAP = mean arterial pressure | | MMP = matrix metalloproteinase | | TIMP = tissue inhibitor of matrix metalloproteinase | | VCFr
= velocity of circumferential shortening |
|
Related Article
-
Embracing Diversity in Remodeling: A Step in Therapeutic Decision Making in Heart Failure?
- Yellaprada Chandrashekhar
J. Am. Coll. Cardiol. 2007 49: 822-825.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. Zheng, Y. Chen, B. Pat, L. A. Dell'Italia, M. Tillson, A. R. Dillon, P. C. Powell, K. Shi, N. Shah, T. Denney, et al.
Microarray Identifies Extensive Downregulation of Noncollagen Extracellular Matrix and Profibrotic Growth Factor Genes in Chronic Isolated Mitral Regurgitation in the Dog
Circulation,
April 21, 2009;
119(15):
2086 - 2095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Marsh, L. J. Dell'Italia, and J. C. Chatham
Interaction of diet and diabetes on cardiovascular function in rats
Am J Physiol Heart Circ Physiol,
February 1, 2009;
296(2):
H282 - H292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Pat, C. Killingsworth, T. Denney, J. Zheng, P. Powell, M. Tillson, A. R. Dillon, and L. J. Dell'Italia
Dissociation between cardiomyocyte function and remodeling with {beta}-adrenergic receptor blockade in isolated canine mitral regurgitation
Am J Physiol Heart Circ Physiol,
December 1, 2008;
295(6):
H2321 - H2327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Colston, S. D. de la Rosa, M. Koehler, K. Gonzales, R. Mestril, G. L. Freeman, S. R. Bailey, and B. Chandrasekar
Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1839 - H1846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Marsh, P. C. Powell, A. Agarwal, L. J. Dell'Italia, and J. C. Chatham
Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis
Am J Physiol Heart Circ Physiol,
July 1, 2007;
293(1):
H292 - H298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chandrashekhar
Embracing Diversity in Remodeling: A Step in Therapeutic Decision Making in Heart Failure?
J. Am. Coll. Cardiol.,
February 20, 2007;
49(7):
822 - 825.
[Full Text]
[PDF]
|
 |
|
|